| Application no. and date | 17794931.0 (espacenet) (Federated) (European Patent Register), 20171024 | | Patent/reg. no. and date | DK/EP 3528839, 20231108 | | Publication date | 20190828 | | Priority no. and date | EP 16195256, 20161024 | | EP pub. no. and date |
EP 3528839 20190828 | | Effective date | | | Applicant/owner | Janssen Pharmaceuticals, Inc., 1125 Trenton-Harbourton Road
Titusville, NJ 08560, US | | Applicant ref. no. | | | Inventor | Adriaansen, Janik, Archimedesweg 4-6
2333 CN Leiden, NL,
Doro, Francesco, Archimedesweg 4-6
2333 CN Leiden, NL,
LABOVITIADI, Olga, Archimedesweg 4-6
2333 CN Leiden, NL,
TONNIS, Wouter, Frank, Archimedesweg 4-6
2333 CN Leiden, NL | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/108 (2006.01) , A61K 47/64 (2017.01) , A61K 47/65 (2017.01) , C08B 37/00 (2006.01) | | Title | EXPEC GLYCOCONJUGATE VACCINE FORMULATIONS | | Int. application no. | EP2017077123 | | Int. publication no. | WO2018077853 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
